Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
Titel:
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
Auteur:
Goldberg, Sarah B Schalper, Kurt A Gettinger, Scott N Mahajan, Amit Herbst, Roy S Chiang, Anne C Lilenbaum, Rogerio Wilson, Frederick H Omay, Sacit Bulent Yu, James B Jilaveanu, Lucia Tran, Thuy Pavlik, Kira Rowen, Elin Gerrish, Heather Komlo, Annette Gupta, Richa Wyatt, Hailey Ribeiro, Matthew Kluger, Yuval Zhou, Geyu Wei, Wei Chiang, Veronica L Kluger, Harriet M